← Scroll for more →
Financial Statements — RNGTW
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 0.93 | 1.06 | 1.21 | 0.01 |
| Total Non-current Assets* | 236.27 | 234.20 | 232.16 | 0.29 |
| Total Assets | 237.20 | 235.26 | 233.37 | 0.30 |
| Total Current Liabilities | 0.14 | 0.14 | 0.09 | -- |
| Total Non-current Liabilities* | 8.05 | 8.05 | 8.05 | -- |
| Total Liabilities | 8.19 | 8.19 | 8.14 | 0.32 |
| Retained Earnings | (7.24) | (7.09) | (6.88) | (0.05) |
| Total Stockholder Equity | (7.24) | (7.09) | (6.88) | (0.02) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|
| Selling, General & Admin | 0.16 | 0.22 | -- |
| Operating Income | (0.16) | (0.22) | (0.04) |
| Net Income | 1.93 | 1.84 | (0.04) |
| Basic EPS | 0.00 | -- | -- |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 |
|---|---|---|---|
| Operating Cash Flow | (121.16) | (200.00) | (32.78) |
| Financing Cash Flow | 15.07 | -- | 42.06 |
← Scroll for more columns →